Navigation Links
Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
Date:6/10/2011

MONMOUTH JUNCTION, N.J., June 10, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced positive data through six treatment cycles (72 weeks total duration) of its Phase 2 clinical trial program for ARIKACE® (liposomal amikacin for inhalation) in cystic fibrosis (CF) patients with Pseudomonas lung infections.  The data were presented at the 34th European Cystic Fibrosis Conference in Hamburg, Germany, by Predrag Minic, M.D., Professor of Pediatrics and Head of Pediatrics Pulmonology Department, Mother and Child Health Institute, Belgrade, Serbia, and co-lead investigator of the study.

The open label Phase 2 study was designed to evaluate ARIKACE over multiple treatment cycles in CF patients with Pseudomonas lung infections.  The study enrolled 49 patients to receive ARIKACE 560 mg once daily for 28 days of therapy, followed by a 56-day off-treatment observation period.  ARIKACE was administered using an optimized, investigational eFlow® Nebulizer System (PARI Pharma GmbH).  

The data demonstrated that ARIKACE, delivered once-daily for 28 consecutive days, followed by 56 days off-treatment, for a total of six cycles, resulted in statistically significant improvement in lung function that was sustained over a 72 week period.  Specifically, inhalation of 560 mg of ARIKACE produced a mean increase in pulmonary function (FEV1) of 11.7% at the end of the 28 day treatment period of the sixth cycle (p<0.0001).  

During the course of the study, FEV1 improvement was also sustained at the end of 56 days off-treatment in each of cycles one through six, with an estimated relative increase in FEV1 of 5.7% (95% CI +3.0%, +8.5%; p=0.0001).  Overall, ARIKACE was well-tolerated during all six cycles, with adverse events reported as consistent with those expected in a population of CF patients receiving inhaled medicines.

"ARIKACE demonstrated
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients
2. NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
3. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
4. Israeli Facility Study Demonstrates MGuard™ Stent System Helps Prevent Distal Embolization
5. VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis
6. PROMUS Element™ Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study
7. Intravenous (IV) Administration of Cempra Pharmaceuticals Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial
8. HERCULES Trial Demonstrates Significant Reduction in Systolic Blood Pressure While Revealing Marker in Hypertensive Patients Does Not Predict Outcomes of Renal Artery Stenting
9. SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease
10. Baxa Corporation Demonstrates End-to-End Environmental Stewardship
11. REMEDIAL II Trial of PLCs RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MENLO PARK, Calif. , March 2, ... (OTCQX: DMPI) (DelMar and the Company), a company ... in new orphan drug indications, today announced that ... U.S. Patent and Trademark Office (USPTO) for patent ... to improve the therapeutic benefit of suboptimally administered ...
(Date:3/2/2015)... Ohio , March 2, 2015  Sarnova, ... the launch of the new www.tri-anim.com ... full-service, specialty healthcare distributor of respiratory, anesthesia and ... country. The site has many ... overall experience, making online shopping and ordering easier ...
(Date:3/2/2015)... , March 2, 2015  Maquet Medical Systems ... it has signed an exclusive distribution agreement with ... flagship product, the Flight 60 mechanical ventilator. The ... providing dependable and affordable mobility. Starting in the ... be sold in the United States ...
Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3
... Midwest college that is producing alumni with sizeable reputations in ... Lilly Endowment to launch a School of Pharmacy. ... Laureate in chemistry, the inventor of Teflon®, the discoverer of ... of the U.S. Food and Drug Administration among its graduates. ...
... 20, 2010 Varian Medical Systems (NYSE: VAR ... quarter of fiscal year 2011 following the close of regular ... be followed by a teleconference available to all interested parties ... to the conference call webcast will be available on the ...
Cached Medicine Technology:Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 2Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy 3Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call 2
(Date:3/2/2015)... York (PRWEB) March 02, 2015 Tyrone ... Idoll Magazine, a medium for the model agency industry, ... find, and buy Mango, Passion Fruit, Pink Grapefruit, Pomegranate, ... 3rd, 2015, after 1pm. , At a cost of ... recently came under fire by announcing the brands commitment ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In Construction ... Construction Week (March 1-7, sponsored by the National Association ... History Month, Robins & Morton is recognizing several women ... the construction industry as a whole. From the craft ... roles in between, each woman has a story to ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... NEW YORK, NY (PRWEB) March 02, 2015 ... kicks off March 2–8 and will provide opportunities for people ... find new ways to help people with MS live their ... recognize progress made and to inspire others to join the ... , Multiple sclerosis, an unpredictable, often disabling disease of the ...
(Date:3/2/2015)... March 02, 2015 Four Seasons Resort Maui ... its 25th anniversary this year, having officially opened its doors ... luxury resort is honoring over 70 employees who started on ... from amongst the approximately 400 original employees. The celebration ... Oceanfront Lawn. , This Four Seasons flagship resort, ...
Breaking Medicine News(10 mins):Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... 20 EmPower Research, LLC, a pioneer in,the ... its,first-ever study on the Indian Contract Research Organization ... Contract Research Industry, (CRO-nicles),captures the industry,s current position, ... top line industry executives first hand. India ...
... SAN DIEGO, Oct. 19 Local youth teamed up ... the San Diego,County Alcohol Policy Panel,s annual Legislative Forum ... as distilled spirits and to,investigate the labeling practices of ... enforcement officers and teachers energy drinks, some,with alcohol some ...
... WASHINGTON, Oct. 19 Following is a statement,by ... Healthcare Products,Association (CHPA), regarding the recommendations issued today ... Advisory Committee and,Pediatric Advisory Committee. At a meeting ... over-the-counter cough and cold medicines in children., ...
... Tablets are specially formulated ... for children, ... the safety and efficacy of many name brand,over-the-counter children,s cough and cold ... of their children,s cold and flu,symptoms. Hyland,s, Inc. is pleased to ...
... to State Supreme Court, WILMINGTON, Del., Oct. 19 ... in the Spelter, W.Va., zinc,smelter class action lawsuit. The ... J. Mobley. "We are extremely disappointed by the ... it has been unfairly punished for doing,the right thing ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... registration statement with the Securities,and Exchange Commission relating to ... stock. In connection with this offering,Arena plans to grant ... to,an additional 1,500,000 shares of common stock to cover ...
Cached Medicine News:Health News:EmPower Research Launches Indian CRO Industry Report 2Health News:Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:Hyland's Homeopathic Medicine Offers Parents Safe, All-Natural Option to Alleviate the Symptoms of Colds 2Health News:DuPont Responds to Spelter, W.Va., Lawsuit Decision 2Health News:Arena Pharmaceuticals Announces Public Offering of Common Stock 2
Straight shafts with two point fixation. Tips separated by 3 mm, each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....
Narrow 12 mm jaws with fine teeth. Serrated handle with polished finish....
Medicine Products: